ACRF Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID).

The total body 3D imaging technology at the core of ACRF ACEMID allows for objective and secure data collection providing highly advanced avatars of people imaged. These avatars enable detailed documentation of all skin surfaces (except soles of feet, scalp and areas covered by clothing). Through the creation of smart software and advanced analysis of the imaging data, additional dermoscopy could in the future be negated and the clinical utility of 3D total body photography will become evident. This will significantly improve lesion identification and tracking in combination with greatly reduced appointment time and healthcare costs. The study is assessing the health economic impact by comparing health care costs of usual care with those of 3D imaging. The Clinical and Health Service Evaluation program of ACRF ACEMID will expand this research from the Queensland site across the three health jurisdictions, developing quality of service assurance standards as well as economic and business models of practice. This considers factors influencing, as well as the process and consequences of implementation, including how to introduce viable solutions into a health system and/or to further upscale use and make it sustainable.